Do genome-wide association scans provide additional information on the variation of plasma adiponectin concentrations?

Atherosclerosis

Volumn 208, Issue 2, 2010, Pages 328-329

  Dallinga Thie, G M ^a   Dullaart, R P F ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOTENSIN II; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTERIAL WALL THICKNESS; ARTICLE; DOWN REGULATION; EXON; GENETIC VARIABILITY; GENOME ANALYSIS; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; PROTEIN SYNTHESIS; REGULATORY MECHANISM; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 74749101060     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.12.014     Document Type: Note

References (21)

1. Swarbrick M.M., and Havel P.J. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 6 (2008) 87-102
2. Maeda K., Okubo K., Shimomura I., et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221 (1996) 286-289
3. Yamauchi T., and Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular disease. Int J Obes 32 (2008) S13-S18
4. Yu Y.H., and Ginsberg H.N. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 96 (2005) 1042-1052
5. Rasouli N., and Kern P.A. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93 (2008) S64-S73
6. Kern P.A., Di Gregorio G.B., Lu T., Rassouli N., and Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52 (2003) 1779-1785
7. Fasshauer M., and Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 46 (2003) 1594-1603
8. Dullaart R.P., Riemens S.C., Meinardi J.R., Wolffenbuttel B.H., and Sluiter W.J. Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox. Scand J Clin Lab Invest 65 (2005) 523-531
9. Lely A.T., Krikken J.A., Bakker S.J., et al. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. J Clin Endocrinol Metab 92 (2007) 1821-1826
10. Nishizawa H., Shimomura I., Kishida K., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51 (2002) 2734-2741
11. Bottner A., Kratzsch J., Muller G., et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89 (2004) 4053-4061
12. Li S., Shin H.J., Ding E.L., and Van Dam R.M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302 (2009) 179-188
13. Dullaart R.P., de V.R., van T.A., and Sluiter W.J. Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender. Eur J Endocrinol 156 (2007) 387-394
14. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
15. Sattar N., Wannamethee G., Sarwar N., et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 114 (2006) 623-629
16. Dekker J.M., Funahashi T., Nijpels G., et al. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 93 (2008) 1489-1496
17. Comuzzie A.G., Funahashi T., Sonnenberg G., et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 86 (2001) 4321-4325
18. Gable D.R., Hurel S.J., and Humphries S.E. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 188 (2006) 231-244
19. Heid I.M., Henneman P., Hicks A., et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analysis including 4659 European individuals. Atherosclerosis 208 (2010) 412-420
20. Yang W.S., and Chuang L.M. Human genetics of adiponectin in the metabolic syndrome. J Mol Med 84 (2006) 112-121
21. Heid I.M., Wagner S.A., Gohlke H., et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1727 healthy Caucasians. Diabetes 55 (2006) 375-384